Functional involvements of heterogeneous nuclear ribonucleoprotein A1 in smooth muscle differentiation from stem cells in vitro and in vivo

Stem Cells

Volumn 31, Issue 5, 2013, Pages 906-917

  Huang, Yuan ^a,b   Lin, Luyang ^a,c   Yu, Xiaotian ^a   Wen, Guanmei ^a   Pu, Xiangyuan ^a   Zhao, Hanqing ^a   Fang, Changcun ^a   Zhu, Jianhua ^b   Ye, Shu ^a   Zhang, Li ^b   Xiao, Qingzhong ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ZHEJIANG UNIVERSITY   (China)

^c GUANGZHOU INSTITUTE OF DERMATOLOGY   (China)

Author keywords

Cell differentiation; Heterogeneous nuclear ribonucleoprotein A1; Myocyte specific enhancer factor 2C; Serum response factor; Smooth muscle cells; Stem cells

Indexed keywords

ACTA2 PROTEIN; COLLAGEN TYPE 4; LUCIFERASE; MYOCARDIN; MYOCYTE SPECIFIC ENHANCER FACTOR 2C; NUCLEAR RIBONUCLEOPROTEIN A1; RIBONUCLEOPROTEIN; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR; TRANSGELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUTAGENESIS; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TRANSCRIPTION INITIATION; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE KNOCKDOWN TECHNIQUES; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; MICE; MYOCYTES, SMOOTH MUSCLE; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84876535514     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1324     Document Type: Article

References (57)

1. Xu Q. Stem cells and transplant arteriosclerosis. Circ Res 2008;102:1011-1024. (Pubitemid 351667855)
2. Xiao Q, Wang G, Luo Z et al. The mechanism of stem cell differentiation into smooth muscle cells. Thromb Haemost 2010;104:440-448.
3. Yoshida T, Kaestner KH, Owens GK. Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res 2008;102:1548-1557.
4. Singh N, Trivedi CM, Lu M et al. Histone deacetylase 3 regulates smooth muscle differentiation in neural crest cells and development of the cardiac outflow tract. Circ Res 2011;109:1240-1249.
5. Xie WB, Li Z, Miano JM et al. Smad3-mediated myocardin silencing: A novel mechanism governing the initiation of smooth muscle differentiation. J Biol Chem 2011;286:15050-15057.
6. Grieskamp T, Rudat C, Ludtke TH et al. Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. Circ Res 2011;108:813-823.
7. Zhou J, Hu G, Wang X. Repression of smooth muscle differentiation by a novel high mobility group box-containing protein, HMG2L1. J Biol Chem 2010;285:23177-23185.
8. High FA, Zhang M, Proweller A et al. An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J Clin Invest 2007;117:353-363. (Pubitemid 46203964)
9. Kurpinski K, Lam H, Chu J et al. Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 2010;28:734-742.
10. Xiao Q, Pepe AE, Wang G et al. Nrf3-Pla2g7 interaction plays an essential role in smooth muscle differentiation from stem cells. Arterioscler Thromb Vasc Biol 2012;32:730-744.
11. Wang G, Xiao Q, Luo Z et al. Functional impact of heterogeneous nuclear ribonucleoprotein A2/B1 in smooth muscle differentiation from stem cells and embryonic arteriogenesis. J Biol Chem 2012;287:2896-2906.
12. Xiao Q, Wang G, Yin X et al. Chromobox protein homolog 3 is essential for stem cell differentiation to smooth muscles in vitro and in embryonic arteriogenesis. Arterioscler Thromb Vasc Biol 2011;31:1842-1852.
13. Pepe AE, Xiao Q, Zampetaki A et al. Crucial role of nrf3 in smooth muscle cell differentiation from stem cells. Circ Res 2010;106:870-879.
14. Zhang L, Jin M, Margariti A et al. Sp1-dependent activation of HDAC7 is required for platelet-derived growth factor-BB-induced smooth muscle cell differentiation from stem cells. J Biol Chem 2010;285:38463-38472.
15. Xiao Q, Luo Z, Pepe AE et al. Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2. Am J Physiol Cell Physiol 2009;296:C711-723.
16. He Y, Smith R. Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B. Cell Mol Life Sci 2009;66:1239-1256.
17. Dreyfuss G, Matunis MJ, Pinol-Roma S et al. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 1993;62:289-321. (Pubitemid 23237873)
18. Burd CG, Dreyfuss G. RNA binding specificity of hnRNP A1: Significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J 1994;13:1197-1204. (Pubitemid 24074726)
19. Cobianchi F, Calvio C, Stoppini M et al. Phosphorylation of human hnRNP protein A1 abrogates in vitro strand annealing activity. Nucleic Acids Res 1993;21:949-955. (Pubitemid 23153004)
20. Idriss H, Kumar A, Casas-Finet JR et al. Regulation of in vitro nucleic acid strand annealing activity of heterogeneous nuclear ribonucleoprotein protein A1 by reversible phosphorylation. Biochemistry 1994;33:11382-11390. (Pubitemid 24304305)
21. Izaurralde E, Jarmolowski A, Beisel C et al. A role for the M9 transport signal of hnRNP A1 in mRNA nuclear export. J Cell Biol 1997;137:27-35. (Pubitemid 27167293)
22. Hamilton BJ, Nagy E, Malter JS et al. Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences. J Biol Chem 1993;268:8881-8887. (Pubitemid 23118680)
23. Svitkin YV, Ovchinnikov LP, Dreyfuss G et al. General RNA binding proteins render translation cap dependent. EMBO J 1996;15:7147-7155.
24. Cammas A, Pileur F, Bonnal S et al. Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation of specific mRNAs. Mol Biol Cell 2007;18:5048-5059. (Pubitemid 350246704)
25. Bonnal S, Pileur F, Orsini C et al. Heterogeneous nuclear ribonucleoprotein A1 is a novel internal ribosome entry site trans-acting factor that modulates alternative initiation of translation of the fibroblast growth factor 2 mRNA. J Biol Chem 2005;280:4144-4153. (Pubitemid 40288579)
26. Chabot B, Blanchette M, Lapierre I et al. An intron element modulating 5′ splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1. Mol Cell Biol 1997;17:1776-1786. (Pubitemid 27133262)
27. Del Gatto-Konczak F, Olive M, Gesnel MC et al. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol Cell Biol 1999;19:251-260. (Pubitemid 29018427)
28. Matter N, Marx M, Weg-Remers S et al. Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways. J Biol Chem 2000;275:35353-35360.
29. Mayeda A, Krainer AR. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 1992;68:365-375.
30. Blanchette M, Chabot B. Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J 1999;18:1939-1952. (Pubitemid 29158537)
31. Jiang ZH, Zhang WJ, Rao Y et al. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. Proc Natl Acad Sci USA 1998;95:9155-9160. (Pubitemid 28506201)
32. Zhang QS, Manche L, Xu RM et al. hnRNP A1 associates with telomere ends and stimulates telomerase activity. RNA 2006;12:1116-1128. (Pubitemid 43788129)
33. Ding J, Hayashi MK, Zhang Y et al. Crystal structure of the two-RRM domain of hnRNP A1 (UP1) complexed with single-stranded telomeric DNA. Genes Dev 1999;13:1102-1115. (Pubitemid 29233142)
34. Lau JS, Baumeister P, Kim E et al. Heterogeneous nuclear ribonucleoproteins as regulators of gene expression through interactions with the human thymidine kinase promoter. J Cell Biochem 2000;79:395-406.
35. Donev RM, Doneva TA, Bowen WR et al. HnRNP-A1 binds directly to double-stranded DNA in vitro within a 36 bp sequence. Mol Cell Biochem 2002;233:181-185. (Pubitemid 34746125)
36. Donev R, Horton R, Beck S et al. Recruitment of heterogeneous nuclear ribonucleoprotein A1 in vivo to the LMP/TAP region of the major histocompatibility complex. J Biol Chem 2003;278:5214-5226. (Pubitemid 36801034)
37. Hay DC, Kemp GD, Dargemont C et al. Interaction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription. Mol Cell Biol 2001;21:3482-3490. (Pubitemid 32381784)
38. Xodo L, Paramasivam M, Membrino A et al. Protein hnRNPA1 binds to a critical G-rich element of KRAS and unwinds G-quadruplex structures: Implications in transcription. Nucleic Acids Symp Ser (Oxf) 2008:159-160.
39. Cogoi S, Paramasivam M, Spolaore B et al. Structural polymorphism within a regulatory element of the human KRAS promoter: Formation of G4-DNA recognized by nuclear proteins. Nucleic Acids Res 2008;36:3765-3780. (Pubitemid 351917538)
40. Iervolino A, Santilli G, Trotta R et al. hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis. Mol Cell Biol 2002;22:2255-2266. (Pubitemid 34224631)
41. Margariti A, Xiao Q, Zampetaki A et al. Splicing of HDAC7 modulates the SRF-myocardin complex during stem-cell differentiation towards smooth muscle cells. J Cell Sci 2009;122:460-470.
42. Xiao Q, Zeng L, Zhang Z et al. Stem cell-derived Sca-1+ progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin alpha1/beta1/alphav and PDGF receptor pathways. Am J Physiol Cell Physiol 2007;292:C342-352. (Pubitemid 46127310)
43. Wang Z, Wang DZ, Hockemeyer D et al. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004;428:185-189. (Pubitemid 38374315)
44. Li S, Wang DZ, Wang Z et al. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc Natl Acad Sci USA 2003;100:9366-9370. (Pubitemid 37033934)
45. Long X, Creemers EE, Wang DZ et al. Myocardin is a bifunctional switch for smooth versus skeletal muscle differentiation. Proc Natl Acad Sci USA 2007;104:16570-16575. (Pubitemid 350211059)
46. Miano JM. Serum response factor: Toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003;35:577-593. (Pubitemid 36681543)
47. Takimoto M, Tomonaga T, Matunis M et al. Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro. J Biol Chem 1993;268:18249-18258. (Pubitemid 23260350)
48. Campillos M, Lamas JR, Garcia MA et al. Specific interaction of heterogeneous nuclear ribonucleoprotein A1 with the -219T allelic form modulates APOE promoter activity. Nucleic Acids Res 2003;31:3063-3070. (Pubitemid 37441765)
49. Xia H. Regulation of gamma-fibrinogen chain expression by heterogeneous nuclear ribonucleoprotein A1. J Biol Chem 2005;280:13171-13178.
50. Chen H, Hewison M, Hu B et al. Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: A cause of vitamin D resistance. Proc Natl Acad Sci USA 2003;100:6109-6114. (Pubitemid 36576939)
51. Das S, Ward SV, Markle D et al. DNA damage-binding proteins and heterogeneous nuclear ribonucleoprotein A1 function as constitutive KCS element components of the interferon-inducible RNA-dependent protein kinase promoter. J Biol Chem 2004;279:7313-7321. (Pubitemid 38248881)
52. Yoshida T, Sinha S, Dandre F et al. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res 2003;92:856-864. (Pubitemid 36542526)
53. Du KL, Ip HS, Li J et al. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Biol 2003;23:2425-2437. (Pubitemid 36351024)
54. Chen J, Kitchen CM, Streb JW et al. Myocardin: A component of a molecular switch for smooth muscle differentiation. J Mol Cell Cardiol 2002;34:1345-1356. (Pubitemid 35244412)
55. Raphel L, Talasila A, Cheung C et al. Myocardin overexpression is sufficient for promoting the development of a mature smooth muscle cell-like phenotype from human embryonic stem cells. PLoS One 2012;7:e44052.
56. Lin Q, Lu J, Yanagisawa H et al. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 1998;125:4565-4574. (Pubitemid 28564299)
57. Creemers EE, Sutherland LB, McAnally J et al. Myocardin is a direct transcriptional target of Mef2, tead and Foxo proteins during cardiovascular development. Development 2006;133:4245-4256. (Pubitemid 44830668)